Trabectedin mechanism of action: what’s new?

ISSN： 1479-6694

Source： Future Oncology, Vol.9, Iss.12, 2013-12, pp. : 5-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biology of ovarian cancer and trabectedin mechanism of action

By Ray-Coquard Isabelle

Future Oncology, Vol. 9, Iss. 12, 2013-12 ,pp. : 11-17

Future Medicine

Access to resources Recommend Favorite

Introduction: What mechanism(s) drive hypermutation?

By Reynaud C.A. Quint L. Bertocci B. Weill J.C.

Seminars in Immunology, Vol. 8, Iss. 3, 1996-03 ,pp. : 125-129

Academic Press

Access to resources Recommend Favorite

If cancer stem cells are resistant to current therapies, what’’s next?

By Marcato Paola Dean Cheryl A Giacomantonio Carman A Lee Patrick WK

Future Oncology, Vol. 5, Iss. 6, 2009-08 ,pp. : 747-750

Future Medicine

Access to resources Recommend Favorite

On the Mechanism of the Radioprotective Action of Cyanide

By van der Meer C. Zaalberg O. Brocades Vos O. Vergroesen A.J. van Bekkum D.W.

International Journal of Radiation Biology, Vol. 4, Iss. 3, 1962-01 ,pp. : 311-319

Informa Healthcare

Access to resources Recommend Favorite

Cytotoxicity and mechanism of action of a new ROS-generating microsphere formulation for circumventing multidrug resistance in breast cancer cells

By Liu Qun Shuhendler Adam Cheng Ji Rauth Andrew O’Brien Peter Wu Xiao

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 323-333

Springer Publishing Company

Access to resources Recommend Favorite